SPANXN3
gene geneOn this page
Also known as SPANX-N3CT11.8
Summary
SPANXN3 (SPANX family member N3, HGNC:33176) is a protein-coding gene on chromosome Xq27.3, encoding Sperm protein associated with the nucleus on the X chromosome N3 (Q5MJ09).
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 17 total
- MANE Select transcript:
NM_001009609
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33176 |
| Approved symbol | SPANXN3 |
| Name | SPANX family member N3 |
| Location | Xq27.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SPANX-N3, CT11.8 |
| Ensembl gene | ENSG00000189252 |
| Ensembl biotype | protein_coding |
| OMIM | 300666 |
| Entrez | 139067 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000370503
RefSeq mRNA: 1 — MANE Select: NM_001009609
NM_001009609
CCDS: CCDS35418
Canonical transcript exons
ENST00000370503 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001452872 | 143508735 | 143509162 |
| ENSE00001452873 | 143517314 | 143517475 |
Expression profiles
Bgee: expression breadth broad, 31 present calls, max score 93.25.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0909 / max 29.7716, expressed in 25 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 200752 | 0.0909 | 25 |
Top tissues by expression
97 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 93.25 | gold quality |
| right testis | UBERON:0004534 | 92.56 | gold quality |
| left testis | UBERON:0004533 | 92.55 | gold quality |
| testis | UBERON:0000473 | 92.26 | gold quality |
| duodenum | UBERON:0002114 | 59.48 | gold quality |
| bone marrow cell | CL:0002092 | 38.57 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| left adrenal gland | UBERON:0001234 | 34.34 | silver quality |
| right uterine tube | UBERON:0001302 | 33.76 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 33.38 | gold quality |
| bone marrow | UBERON:0002371 | 32.97 | gold quality |
| adrenal gland | UBERON:0002369 | 32.28 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| metanephros cortex | UBERON:0010533 | 31.78 | silver quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| muscle of leg | UBERON:0001383 | 30.90 | gold quality |
| gastrocnemius | UBERON:0001388 | 30.81 | gold quality |
| right coronary artery | UBERON:0001625 | 30.27 | silver quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| liver | UBERON:0002107 | 28.71 | gold quality |
| right adrenal gland | UBERON:0001233 | 28.53 | gold quality |
| cortex of kidney | UBERON:0001225 | 28.04 | silver quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.65 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (4): SPANXN4 (ENSG00000189326), SPANXN1 (ENSG00000203923), SPANXN5 (ENSG00000204363), SPANXN2 (ENSG00000268988)
Protein
Protein identifiers
Sperm protein associated with the nucleus on the X chromosome N3 — Q5MJ09 (reviewed: Q5MJ09)
Alternative names: Nuclear-associated protein SPAN-Xn3, SPANX family member N3
All UniProt accessions (1): Q5MJ09
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the SPAN-X family.
RefSeq proteins (1): NP_001009609* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR010007 | SPAN-X_fam | Family |
Pfam: PF07458
UniProt features (10 total): compositionally biased region 5, region of interest 2, sequence variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5MJ09-F1 | 64.36 | 0.04 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 4 (showing top):
chrXq27, DACH1_TARGET_GENES, DESCARTES_FETAL_INTESTINE_INTESTINAL_EPITHELIAL_CELLS, GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
394 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPANXN3 | PSG3 | Q16557 | 598 |
| SPANXN3 | SPANXD | Q9BXN6 | 583 |
| SPANXN3 | EOLA2 | Q96DE9 | 570 |
| SPANXN3 | CXorf51A | A0A1B0GTR3 | 545 |
| SPANXN3 | ADH4 | P08319 | 526 |
| SPANXN3 | SSX7 | Q7RTT5 | 447 |
| SPANXN3 | EOLA1 | Q8TE69 | 446 |
| SPANXN3 | RIBC1 | Q8N443 | 436 |
| SPANXN3 | HSFX4 | A0A1B0GTS1 | 417 |
| SPANXN3 | PER2 | O15055 | 413 |
| SPANXN3 | ENO4 | A6NNW6 | 411 |
| SPANXN3 | XAGE3 | Q8WTP9 | 398 |
| SPANXN3 | FMR1NB | Q8N0W7 | 398 |
| SPANXN3 | CYLC1 | P35663 | 390 |
| SPANXN3 | TENT5D | Q8NEK8 | 390 |
IntAct
51 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SPANXN3 | SUOX | psi-mi:“MI:0914”(association) | 0.640 |
| SPANXN3 | STAC3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPANXN3 | CEP70 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPANXN3 | MEOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SP4 | SPANXN3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF143 | SPANXN3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SDCBP | SPANXN3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF76 | SPANXN3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPANXN3 | ATP6V1C2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPANXN3 | FAM228A | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPANXN3 | AARSD1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPANXN3 | PBX4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HAND2 | SPANXN3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPANXN3 | FAM217B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPANXN3 | CAVIN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPANXN3 | YAF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPANXN3 | RAD23A | psi-mi:“MI:0914”(association) | 0.530 |
| SPANXN3 | SRPRA | psi-mi:“MI:0915”(physical association) | 0.400 |
| SPANXN3 | OGA | psi-mi:“MI:0914”(association) | 0.350 |
| SPANXN3 | STAC3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SPANXN3 | CEP70 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SPANXN3 | MEOX2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SPANXN3 | SP4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SPANXN3 | CAVIN1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SPANXN3 | ZNF143 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SPANXN3 | SDCBP | psi-mi:“MI:0915”(physical association) | 0.000 |
| ATP6V1C2 | SPANXN3 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (40): CMSS1 (Affinity Capture-MS), EHD1 (Affinity Capture-MS), IMPDH1 (Affinity Capture-MS), FBXW11 (Affinity Capture-MS), BTRC (Affinity Capture-MS), FBXW2 (Affinity Capture-MS), SUOX (Affinity Capture-MS), ARIH1 (Affinity Capture-MS), FBXW2 (Affinity Capture-MS), BTRC (Affinity Capture-MS), FBXW11 (Affinity Capture-MS), SUOX (Affinity Capture-MS), ARIH1 (Affinity Capture-MS), CMSS1 (Affinity Capture-MS), CUL1 (Affinity Capture-MS)
ESM2 similar proteins: A0A0U1RQG5, A1L429, A4FU49, A6NDE8, A6NER3, A6NGK3, O75459, O76087, P0C2W7, P0C2X8, P0C671, P0C7A2, P0CL80, P0CL81, P0CL82, P0DSO3, P0DTW1, P49919, Q0ZNK1, Q13066, Q13069, Q13070, Q28181, Q4V321, Q4V326, Q5H9L2, Q5MJ09, Q5SS00, Q5VWK0, Q6IPX3, Q6NT46, Q6P6B1, Q6PGQ1, Q6SJ82, Q70KF4, Q8CCT4, Q8IYN2, Q8N660, Q8NDB6, Q8R0A5
Diamond homologs: Q0ZNK1, Q5MJ07, Q5MJ08, Q5MJ09, Q5MJ10, Q5VSR9, Q6SJ82, Q6SJ84, Q6SJ91, Q9BXN6, Q9NS26, Q9NY87, Q9NS25
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
17 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 16 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
243 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:143517310:TTA:T | donor_loss | 1.0000 |
| X:143517311:TA:T | donor_loss | 1.0000 |
| X:143517312:ACCTC:A | donor_loss | 1.0000 |
| X:143517313:CCT:C | donor_gain | 1.0000 |
| X:143517312:A:AC | donor_gain | 0.9900 |
| X:143517313:C:CC | donor_gain | 0.9900 |
| X:143509163:C:CC | acceptor_gain | 0.9800 |
| X:143517312:ACCT:A | donor_gain | 0.9700 |
| X:143517313:CCTC:C | donor_gain | 0.9700 |
| X:143509160:CATCT:C | acceptor_loss | 0.9600 |
| X:143509161:ATCTG:A | acceptor_loss | 0.9600 |
| X:143509162:TC:T | acceptor_loss | 0.9600 |
| X:143509163:CT:C | acceptor_loss | 0.9600 |
| X:143509164:T:A | acceptor_loss | 0.9600 |
| X:143509160:CAT:C | acceptor_gain | 0.9500 |
| X:143517313:CCTCA:C | donor_gain | 0.9400 |
| X:143517315:T:TA | donor_gain | 0.9000 |
| X:143509166:G:C | acceptor_gain | 0.8800 |
| X:143517311:TAC:T | donor_gain | 0.8800 |
| X:143517310:TTACC:T | donor_gain | 0.8600 |
| X:143517309:CTTA:C | donor_gain | 0.8300 |
| X:143517312:AC:A | donor_gain | 0.8300 |
| X:143517313:CC:C | donor_gain | 0.8300 |
| X:143517312:A:T | donor_gain | 0.8200 |
| X:143509161:AT:A | acceptor_gain | 0.8100 |
| X:143517006:T:A | donor_gain | 0.8000 |
| X:143510545:CTCTT:C | acceptor_gain | 0.7900 |
| X:143509159:GCAT:G | acceptor_gain | 0.7600 |
| X:143509160:CATC:C | acceptor_gain | 0.7600 |
| X:143517308:TCTTA:T | donor_gain | 0.7600 |
AlphaMissense
928 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS111381212 (X:143509214 A>C,G,T), RS111851873 (X:143517726 G>A,C), RS111865676 (X:143514265 T>A,C), RS111877285 (X:143517627 T>C), RS112319223 (X:143517675 G>C,T), RS112435034 (X:143515587 C>T), RS112442093 (X:143517609 C>A,T), RS112719440 (X:143517804 C>T), RS112726334 (X:143517714 C>T), RS112896911 (X:143518342 A>G,T), RS113043096 (X:143508927 C>G,T), RS113076693 (X:143517861 T>C), RS113133860 (X:143517677 T>C), RS113490027 (X:143517106 T>C), RS113758209 (X:143509210 T>C,G)
Disease associations
OMIM: gene MIM:300666 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006014_32 | Creatine kinase levels | 7.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004534 | creatine kinase measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 2-methyl-4-isothiazolin-3-one | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Calcitriol | increases expression | 1 |
| Citrulline | increases expression | 1 |
| Malathion | decreases expression | 1 |
| Thiram | increases expression | 1 |
| Vanadates | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.